Press Release - November 1st, 2023 SubjectWell Acquires PatientCentra Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers full-service, global patient recruitment capabilities plus an in-house agency for the development of tailored, patient-centric recruitment journeys. Through this acquisition, SubjectWell now serves the patient recruitment needs of any international clinical study, while expanding its ability to recruit for rare disease and oncology indications. “SubjectWell’s global customer base has been asking for our recruitment support on large, multi-country trials – and we listened,” said Fred Martin, CEO, SubjectWell. “PatientCentra has 15 years of experience delivering digitally enabled patient recruitment programs on 5 different continents. When added to SubjectWell’s unrivaled access to motivated patients with known conditions in North America, together we accelerate our ability to support life-improving research on a global scale.” “The PatientCentra team and I are proud to be joining SubjectWell,” said Dan Stempel, founder and CEO, PatientCentra. “We see a huge opportunity to offer our customized clinical recruitment solutions, including multi-channel outreach, patient websites and concierge support to SubjectWell’s marquee customer base. Our combined customers can now rely on one company for end-to-end, global patient recruitment support for vaccine, chronic conditions, rare disease, and oncology studies.” About SubjectWell SubjectWell is the patient access marketplace, connecting patients with chronic health conditions to trials and treatments. Since 2012, SubjectWell has been raising awareness of the benefits of clinical research, registering tens of millions of healthcare-motivated patients with known conditions. At SubjectWell, we already have the patients you need. Visit SubjectWell.com to find out more. About MD Connect, Inc. For more than 15 years, MD Connect, Inc. has helped hundreds of leading healthcare organizations acquire patients using customized multi-channel digital outreach and patient lead tracking technologies. Backed by data and the experience of having driven millions of patient leads in over 30 specialties, MD Connect, Inc. leverages their knowledge base to map custom digital patient journeys that go well beyond an initial patient inquiry. PatientCentra, the largest and fastest growing component of MD Connect, Inc., provides global patient recruitment and compliance services, combining innovative outreach strategies with state-of-the-art technologies and a suite of site support services designed to ease the burden on patients, sites, and sponsors. Find out more at PatientCentra.com. Media Contact Jillian Hammell Crowley Webb for SubjectWell jillian.hammell@crowleywebb.com, 716.844.7237
Acquisition unlocks ability to recruit for global trials, as well as rare disease and oncology indications AUSTIN, TX, November 2, 2023 – SubjectWell, the patient access marketplace that connects patients with chronic health conditions to new care options, today announced the acquisition of PatientCentra, an MD Connect, Inc. business. Located in Waltham, MA, PatientCentra offers full-service, global patient recruitment capabilities plus an in-house agency for the development of tailored, patient-centric recruitment journeys. Through this acquisition, SubjectWell now serves the patient recruitment needs of any international clinical study, while expanding its ability to recruit for rare disease and oncology indications. “SubjectWell’s global customer base has been asking for our recruitment support on large, multi-country trials – and we listened,” said Fred Martin, CEO, SubjectWell. “PatientCentra has 15 years of experience delivering digitally enabled patient recruitment programs on 5 different continents. When added to SubjectWell’s unrivaled access to motivated patients with known conditions in North America, together we accelerate our ability to support life-improving research on a global scale.” “The PatientCentra team and I are proud to be joining SubjectWell,” said Dan Stempel, founder and CEO, PatientCentra. “We see a huge opportunity to offer our customized clinical recruitment solutions, including multi-channel outreach, patient websites and concierge support to SubjectWell’s marquee customer base. Our combined customers can now rely on one company for end-to-end, global patient recruitment support for vaccine, chronic conditions, rare disease, and oncology studies.” About SubjectWell SubjectWell is the patient access marketplace, connecting patients with chronic health conditions to trials and treatments. Since 2012, SubjectWell has been raising awareness of the benefits of clinical research, registering tens of millions of healthcare-motivated patients with known conditions. At SubjectWell, we already have the patients you need. Visit SubjectWell.com to find out more. About MD Connect, Inc. For more than 15 years, MD Connect, Inc. has helped hundreds of leading healthcare organizations acquire patients using customized multi-channel digital outreach and patient lead tracking technologies. Backed by data and the experience of having driven millions of patient leads in over 30 specialties, MD Connect, Inc. leverages their knowledge base to map custom digital patient journeys that go well beyond an initial patient inquiry. PatientCentra, the largest and fastest growing component of MD Connect, Inc., provides global patient recruitment and compliance services, combining innovative outreach strategies with state-of-the-art technologies and a suite of site support services designed to ease the burden on patients, sites, and sponsors. Find out more at PatientCentra.com. Media Contact Jillian Hammell Crowley Webb for SubjectWell jillian.hammell@crowleywebb.com, 716.844.7237
